MDCalc, a company that provides over 800 clinical tools and calculators to doctors, is launching a quality-rating system to address the lack of transparency around bias and validity in these calculators.
Regenxbio said on Monday that the agency took another step toward clearing a backlog of Makary-era rejections that appeared to contradict earlier agreements with drugmakers.
A new study published in Nature Medicine on June 25, 2026, found that neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab significantly improved clinical responses for patients with early-stage ER+HER2− breast cancer.
According to a recent phase 2/3 study published in Nature Medicine on June 30, 2026, digital AVATAR therapy has shown promise in treating distressing voices in psychosis.
The FDA has announced plans to reconsider its approval process for gene therapies, following a recent petition from advocacy groups urging the agency to withdraw its approval of the use of antibiotics in livestock.
Researchers have discovered that blood signatures of cell type-specific aging can forecast disease risk and resilience, according to a study published in Nature Medicine on June 15, 2026.